Study 7 of 7Dulaglutide literatureThe lancet. Diabetes & endocrinologyTop journal2026
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial.
Not reported in abstract.
Where it sits
this study against the rest of the dulaglutide corpus1
Preclinical · this one
5
Observational
0
Open-label
0
Randomised
1
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the Dulaglutide corpus
ASerial assessment of NT-proBNP and high-sensitivity cardiac troponin with glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes: Insights from EXSCEL.American heart journal · 2026 · n=4292 · Adjusted HR per 1 integer unit of baseline NT-proBNP for MACE was 1.63, P < .001.HumanBVirtual shared medical appointments for obesity and GLP-1 medications: A scalable method for optimizing care delivery.Obesity pillars · 2026 · n=54 · Weight decreased from 227 lb (53 lb) to 211 lb (46 lb), n=17.HumanBClinical perspectives on pediatric weight-management programs: A nationwide look at models of care.Obesity pillars · 2026 · n=38 · Not reported in abstract.HumanBCalculating cost per event avoided using a composite number needed to treat.Journal of medical economics · 2026 · $1,884,013 for CPEA of dulaglutide MACE-3HumanACardiorenal protective effects of glucagon-like peptide-1 receptor agonists in chronic kidney disease: a systematic review and meta-analysis.Renal failure · 2026 · n=21717 · RR for all-cause mortality was 0.83; 95% CI, 0.76-0.90.HumanBSevere numbness of the mouth and tongue induced by piperacillin/tazobactam: a rare case report.Future science OA · 2026 · n=1 · Not reported in abstract.Human